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Patients with panic disorder experience panic attacks after
intravenous sodium lactate infusions by an as yet unexplained
mechanism. Lactate elicits a panic-like response in rats with
chronic dysfunction of GABA neurotransmission in the dorso-
medial hypothalamus (DMH). The circumventricular organs, or-
ganum vasculosum lamina terminalis (OVLT) and subfornical
organ (SFO), are potential sites that could detect increases in
plasma lactate levels and activate the DMH. To test this, we
obtained baseline heart rate (HR) and blood pressure (BP)
responses to lactate infusions in rats fit with femoral arterial and
venous catheters. Next, unilateral chronic injection cannulae
connected to an Alzet infusion pump filled with the GABA
synthesis inhibitor L-allylglycine (L-AG) were implanted into the
DMH. Another chronic injection cannula was implanted into the
region of the OVLT, SFO, or an adjacent control site, the median
preoptic area (MePOA). These rats were tested once again with
lactate infusions after injection of either artificial cerebrospinal
fluid (ACSF) or tetrodotoxin (TTX) into the CVO sites. Injecting
TTX into the OVLT completely blocked the lactate-induced
response, whereas TTX injections into the SFO or MePOA did
not. Also, direct injections of lactate (100 or 500 nl) into the
OVLT elicited robust anxiety-like responses in these rats. These
results suggest that the OVLT may be the primary site that
detects lactate infusions, activating an anxiety-like response in
a compromised DMH, and provide the first neuroanatomical
basis for lactate response in panic disorder.
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Panic disorder is a severe anxiety disorder characterized by
recurrent panic attacks, i.e., episodes of extreme anxiety accom-
panied by multiple physiological symptoms of arousal. A majority
of patients with panic disorder also experience a panic attack
when given intravenous infusions of sodium lactate (Pitts and
McClure, 1967; Reiman et al., 1984; Liebowitz et al., 1986).
Blocking GABAA neurotransmission in the dorsomedial hypo-
thalamus (DMH) of rats elicits a dramatic, panic-like response
characterized by increases in heart rate (HR), respiratory rate
(RR), blood pressure (BP), and many behavioral measures of
anxiety and fear (DiMicco et al., 1992; Shekhar, 1993; Shekhar
and Katner; 1995), a response that is blocked by anti-panic
treatments (Shekhar, 1994). Furthermore, rats that have a dys-
function of GABA in the DMH show a susceptibility to physio-
logical arousal by lactate infusions similar to patients with panic
disorder (Shekhar et al., 1996). Unilateral GABA dysfunction
was induced in the DMH of rats by chronically infusing, via Alzet
minipumps, L-allylglycine (L-AG), which inhibits glutamic acid
decarboxylase (GAD), the synthetic enzyme for GABA (Or-
lowski et al., 1977). Rats with GABA dysfunction specifically in
the DMH showed significant increases in baseline anxiety and
developed anxiety-like responses with intravenous lactate infu-
sions (Shekhar et al., 1996).
Understanding the neural pathways by which intravenous lac-
tate infusions interact with a compromised DMH to elicit a
panic-like response in rats, i.e., lactate vulnerability, would be
important in understanding the pathophysiology of human panic
disorder. The DMH has extensive projections to and from several
circumventricular organs (CVOs), areas in the CNS that lack a
blood–brain barrier (Ter Horst and Luiten, 1986) and therefore
serve as “sensors” of changes in osmolarity, pH, and other plasma
parameters (Buggy et al., 1979; Thrasher and Keil, 1987; Richard
and Bourque, 1992; Johnson and Gross, 1993; Kovacs and
Sawchenko, 1993). These anatomical connections suggest a po-
tential mechanism by which many peripheral plasma parameters
can be relayed to the DMH. Among the three major circumven-
tricular organs that receive afferents from the DMH, i.e., the area
postrema (AP), subfornical organ (SFO), and organum vasculo-
sum lamina terminalis (OVLT), the OVLT and, to a lesser
extent, the SFO have projections back to the DMH (Ter Horst
and Luiten, 1986). Thus the OVLT and possibly the SFO could
play a critical role in detecting peripheral lactate infusions first
and then in activating an already compromised DMH by their
efferents, resulting in physiological arousal.
If sensory information about peripheral lactate infusions aris-
ing from the CVOs is essential for the DMH-mediated anxiety
response, then blocking neural transmission by injecting tetrodo-
toxin (TTX; Bosker et al., 1994; Corwin et al., 1995) into the
OVLT and/or SFO would be predicted to block the lactate
response. Similarly, if the CVOs are the major “sensory” organs
that relay the lactate stimulus to the DMH, then, in rats with
GABA dysfunction in the DMH, injecting a small volume (100–
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500 nl) of sodium lactate directly into the CVOs also would be
predicted to elicit a panic-like response similar to intravenous
lactate infusions. The present study was conducted to test both of
these hypotheses.
MATERIALS AND METHODS
All experiments were conducted on male Sprague Dawley rats (300–350
gm; Harlan Laboratories, Indianapolis, IN) that were housed in individ-
ual plastic cages in a temperature-controlled room (72°F), kept on a 12 hr
day–night cycle, and given ad libitum food and water.
Surg ical procedures. Rats were implanted first with femoral arterial and
venous catheters as previously described (Shekhar, 1993). The next day,
after being tested for baseline lactate response, they were implanted with
the appropriate Alzet pump in the DMH and the microinjection cannula
in the CVO site. Implantation of Alzet minipumps into the DMH also
has been described previously (Shekhar et al., 1996). An L-shaped pump
cannula with a side arm attached to a small Tygon tube was used for
pump implantations. Once the cannula was placed at the coordinates of
the DMH, 50 pmol/100 nl of the GABAA receptor antagonist bicuculline
methiodide (BMI) was injected through the side tubing to ascertain that
the tip was placed at the reactive site (i.e., where BMI elicits .50
beats/min increases in HR) in the DMH. Once the reactive site was
found, the side tubing was connected to the metal connector in the Alzet
minipump (model 2002) that was filled previously with the desired
infusion fluid. Then the pump was sutured under the skin in the nape of
the neck, and the connector and cannula were cemented to the skull as
described previously (Shekhar et al., 1996). The concentration of the
allylglycine solutions is such that 3.5 nmol/0.5 ml per hour of the drug was
infused into the DMH. Chronic microinjection cannulae were implanted
stereotaxically in the region of the OVLT, SFO, and 1 mm lateral to the
OVLT, corresponding to the medial preoptic area (mePOA). The ste-
reotaxic coordinates from bregma for the sites, using a 10° angle from the
vertical plane with the incisor bar set at 15° included the following:
OVLT, anterior (A) 2.4 mm, lateral (L) 1.0 mm, and ventral (V) 8.5 mm;
SFO, A 0.2 mm, L 1.0 mm, and V 4.5 mm; mePOA, A 2.4 mm, L 2.0 mm,
and V 8.5 mm.
Social interaction test. The social interaction (SI) test is a fully validated
test of experimental anxiety in rats (File, 1980), and the procedure as
used in our laboratory has been described previously (Sanders and
Shekhar, 1995; Shekhar and Katner, 1995). The apparatus itself consists
of a solid wooden box with an open roof 36 3 36" wide with walls 12"
high. A video camera is fixed above the box, and all behavioral tests are
videotaped. The “experimental” rat and an unfamiliar “partner” rat are
both placed in the center of the box and allowed to interact freely for a
period of 5 min. Then the number of seconds of nonaggressive physical
contact (grooming, sniffing, crawling over and under, etc.) initiated by the
“experimental” rat is counted. Sessions are scored at a later time by two
raters, of whom at least one is blind to any drug treatment.
Measurement of GAD activity. The radiometric assay for GAD (mod-
ified from Bostwick and Le, 1991; Shekhar et al., 1996) was based on
supplying the enzyme with glutamate (substrate) with a 14C-labeled
carboxyl group and measuring the liberated 14CO2. The tissue was
homogenized with 20 vol of a solution containing EDTA (1 mM), Triton
X-100 (0.2% v/v), and aminoethanethiol (1 mM) in phosphate buffer, pH
7. Each well of tissue culture plate (Falcon 3070) received 10 ml of tissue
homogenate or blank (in triplicates) and 10 ml of buffer substrate (glu-
tamate 12.5 mM; pyridoxal phosphate 0.5 mM; and 14C-glutamate, 4 mCi
in 10 mM PO4 buffer) after which the plate was covered with a 14 3 11
cm sheet of gel blot paper, latched shut, incubated in a 37°C water bath
for 30 min, and then transferred to a 60°C bath for 45 min. The method
for measuring the trapped 14CO2 has been described previously
(Bostwick and Le, 1991).
Experimental procedure. First, rats (n 5 24) were fit with femoral
arterial catheters for recording BP and HR and with venous catheters for
intravenous infusions. After recovery, baseline anxiety levels were ob-
tained by using the SI test to measure the change in “anxiety” from
baseline state (i.e., before Alzet pump implantation into the DMH) to
the postpump state. After the baseline SI test, baseline reactivity to
intravenous sodium lactate infusions was determined. The lactate infu-
sion procedure has been described previously (Shekhar et al., 1996).
Briefly, rats are given intravenous infusions of 0.9% saline and 0.5 M
sodium lactate (10 ml/kg over 15 min), similar to clinical lactate infusions
(Leibowitz et al., 1986), in random order with at least 60 min recovery
time between infusions. The intravenous infusions are given while the
rats are freely mobile in their home cages. Responses to lactate (HR and
BP) that are reported are the differences between changes elicited by
lactate and saline infusions.
Then the animals were randomly assigned to four groups (n 5 6 each):
(1) rats implanted with unilateral L-AG Alzet minipumps into the DMH
Figure 1. Representative photomicro-
graph of histological sections (magnifica-
tion, 83) showing (A) the site of Alzet
pump cannula implantation (marked by
arrow) in the DMH. The sites were
marked by injecting 50% India ink, and
only data from the animals with proper
cannulae placement were used in the
analysis. The injection site is impreg-
nated with India ink, and some tissue
necrosis at the site can be seen. However,
B shows a higher magnification (323)
photomicrograph of the DMH (area
marked by the black rectangle in A) on the
side of the cannula implantation, demon-
strating that the implantation of the Al-
zet pumps did not result in the destruc-
tion of cells in the majority of the DMH,
thereby decreasing GAD activity. Fur-
ther, the same degree of cannula damage
was seen in the DMH of rats implanted
with D-AG pumps, suggesting that the
possible tissue damage was not causing
the lactate response. DMH, Dorsomedial
hypothalamus; F, fornix; mt, mamillotha-
lamic tract; VMH, ventromedial hypo-
thalamus; 3V, third ventricle.
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and chronic microinjection cannulae into the OVLT; (2) rats implanted
with unilateral D-AG Alzet minipumps into the DMH and chronic
microinjection cannulae into the OVLT; (3) rats implanted with unilat-
eral L-AG Alzet minipumps into the DMH and chronic microinjection
cannulae into the region lateral to OVLT, i.e., medial preoptic area
(mePOA); and (4) rats implanted with unilateral L-AG Alzet minipumps
into the DMH and chronic microinjection cannulae into the SFO.
The responses of these rats in the SI test and to lactate infusions were
obtained on postpump day 4, as described previously, to establish that the
rats that had L-AG pumps (and not D-AG pumps) had become more
anxious and responsive to lactate. On postpump day 5 the animals were
injected in random order, both saline vehicle (100 and 500 nl) and sodium
lactate (100 and 500 nl of 0.5N solution) directly into the appropriate
CVO site (OVLT, SFO, or mePOA). The rats were injected while they
were freely mobile in their home cages and had settled down without
significant baseline activity for at least 15 min. There was an interval of
at least 30 min between one injection and the end of the response from
the previous injection. The changes in HR, BP, and locomotor activity
were recorded. The locomotor responses were quantified as the number
of crossings and rearings during the first 5 min after lactate injections.
Each time the rat crossed the midline of the cage with all four limbs, it
was counted as crossing; vertical movement with both front limbs off the
ground was counted as a rearing, as previously described (Shekhar and
DiMicco, 1987).
On postpump days 6 and 7 one-half of each group was injected first
with vehicle (ACSF) into the CVO site; the other one-half was injected
with TTX into the CVO site [as tetrodotoxin citrate, 100 nl of 10 mM
solution, i.e., 1 pmol; doses based on Bosker et al. (1994) and Corwin et
al. (1995)]. Approximately 10 min later, animals were given intravenous
lactate infusions as previously described, and the HR and BP responses
were recorded. Thus, by random selection, one-half of each group (n 5
3) was given vehicle injection on day 6 and the other one-half was given
active drug (TTX) injection into the CVO site on day 6; on day 7 they
received the remaining injection for their assigned group.
After day 7 the rats were killed, and their brains were removed and
mounted on cryostat at 220°C; 40 mm sections of the implantation sites
were obtained. The sections were stained later with neutral red, and the
sites of injection were determined by comparing them with a standard
atlas (Paxinos and Watson, 1986). The brain section containing the
remaining DMH was mounted on a frozen platform. The DMH was
microdissected, weighed, and stored in a 270°C freezer until assayed. At
a later date, tissue levels of the GABA synthetic enzyme GAD were
determined.
Data analysis. All data were expressed as mean 6 SEM. When two or
more means of different groups were compared, one-way ANOVA with
Fisher’s least significant difference (LSD) tests was used. Repeated
measures ANOVA was used to test differences between means when
repeated measurements were made. Statistical significance was accepted
with p , 0.05.
RESULTS
Figure 1 shows the photomicrographs of a representative section
from a rat with the pump implanted in the DMH (Fig. 1). All 24
animals used in the study were ones with successful implantation
in the DMH and the appropriate CVO sites. All of the DMH
sites of implantation also were verified physiologically by injecting
BMI under anesthesia and obtaining increases in HR and BP.
Figure 1B presents the site of pump infusion at a higher magni-
fication, showing that although there is some damage in the
DMH because of pump implantation, particularly in the India
ink-impregnated area, the majority of the neurons of the DMH is
still intact surrounding the injection spot marked by India ink.
Also, the amount of neuronal damage was similar in the L-AG-
infused and the D-AG-infused animals, suggesting that nonspe-
cific injury to the DMH was not causing the lactate response.
Rats that were assigned to L-AG pumps in the DMH and
microinjection cannulae in the OVLT were tested at baseline in
the SI test and with intravenous lactate infusions. There was no
Figure 2. Changes in (A) heart rate (HR) and (B) blood pressure (BP)
after intravenous infusions of sodium lactate (10 ml/kg of 0.5N solution)
in rats that were implanted unilaterally with the GABA synthesis inhibitor
L-allylglycine-infusing (L-AG) Alzet minipumps into the dorsomedial
hypothalamus (DMH ). On postpump day 6/7, rats were injected, in
random order, either with tetrodotoxin (TTX; 1 pmol in 100 nl) or with
vehicle (ACSF) into the organum vasculosum stria terminalis (OVLT )
before intravenous lactate infusions. Data are presented as mean 6 SEM.
Symbols show significant difference from baseline (*) and at 4 d (#) after
L-AG pump in the DMH; p , 0.05, repeated measures ANOVA with
Fisher’s LSD test.
Table 1. Effects on implanting Alzet pumps into the DMH, infusing
L- or D-allylglycine on the social interaction test
Type of Alzet pump
in the DMH (n 5 6
each)
Site of CVO
cannula
SI time before
pump (sec)
SI time 4 d after
pump (sec)
L-Allylglycine OVLT 49 6 4 14 6 3*
D-Allylglycine OVLT 45 6 2 49 6 3
L-Allylglycine mePOA 51 6 3 21 6 2*
L-Allylglycine SFO 49 6 3 24 6 3*
Rats were implanted with Alzet pumps into the DMH, infusing the GABA synthe-
sis inhibitor L-AG or its inactive isomer D-AG; SI time was measured before and 4 d
after pump implantations. These rats also were implanted with their appropriate
CVO cannulae for additional injections later. In all groups the rats implanted with
L-AG pumps showed significant decreases in SI time by day 4 of pump implantation,
indicating an increase in their basal levels of anxiety.
*Significantly different from before pump by repeated measure ANOVA, coupled
with Fisher’s LSD test; p , 0.05.
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Figure 3. Changes (mean 6 SEM) in (A) heart rate (HR), (B) blood pressure (BP), (C) number of cage crossings, and (D) rearings after direct
injections of either sodium lactate (100 and 500 nl of 0.5N solution) or saline (100 or 500 nl) into the OVLT of rats that had L-AG Alzet infusion pumps
implanted into the DMH for 5 d. Injection of lactate directly into the OVLT elicited a robust panic-like response. Symbols show significant difference
from saline control (*) and 100 nl of lactate (#) by repeated measures ANOVA with Fisher’s LSD; p , 0.05.
Table 2. Effects of implanting Alzet pumps into the DMH, infusing L- or D-allylglycine on the glutamic
acid decarboxylase (GAD) activity in the DMH
Type of Alzet pump
in the DMH (n 5 6
each)
Site of
CVO cannula
GAD activity on the nonpump
side (pmol/mg of protein per
30 min)
GAD activity on the pump
side (pmol/mg of protein
per 30 min)
L-Allylglycine OVLT 1216 6 151 704 6 40*
D-Allylglycine OVLT 1060 6 71 1046 6 77
L-Allylglycine mePOA 1346 6 97 728 6 75*
L-Allylglycine SFO 1139 6 194 671 6 82*
Rats were implanted with Alzet pumps into the DMH, infusing the GABA synthesis inhibitor L-AG or its inactive isomer
D-AG; GAD activity was measured after completion of all experiments on day 7 of pump implantation. These rats also were
implanted with their appropriate CVO cannulae for additional injections later. In all groups the rats implanted with L-AG
pumps showed significant decreases in GAD activity within the DMH on the side of pump implantation.
*Significantly different from before pump by repeated measure ANOVA, coupled with Fisher’s LSD test; p , 0.05.
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significant physiological arousal with lactate infusions before
pump implantation (Fig. 2A,B, baseline). They were placed in the
SI test again on postpump day 4 to determine changes in their
anxiety level. As predicted, L-AG pumps in the DMH elicited a
significant decrease in SI time in these rats, indicating that they
were more anxious (Table 1; F(1,10) 5 44.5; p , 0.0001). On
postpump day 4 these animals also had become reactive to intra-
venous lactate infusions, with significant increases in HR and BP
(Fig. 2A,B, day 4). Injection of TTX or vehicle into the OVLT,
followed by infusion with intravenous sodium lactate in these rats,
revealed that TTX and not ACSF completely blocked the re-
sponse to lactate infusions (Fig. 2A,B). When saline or sodium
lactate was injected directly into the OVLT of these rats on
postpump day 5, they showed lactate volume-dependent increases
in HR, BP (Fig. 3A,B), and locomotor activity quantified as
crossings and rearings (Fig. 3C,D) when compared with saline
injections. Measuring GAD activity in the DMH at the end of the
experiment revealed that these animals did, indeed, have signif-
icant decreases in GAD activity on the pump side as compared
with the nonpump side (Table 2; F(1,10) 5 10.8; p 5 0.008). Figure
4 is a representative histological section showing the site of
injection in the OVLT. Thus, in this group with unilateral GABA
dysfunction in the DMH, blocking neuronal activity in the
OVLT with TTX abolished the lactate response, whereas direct
injections of lactate into the OVLT elicited robust physiological
and behavioral responses.
In contrast, rats that had D-AG pumps in the DMH and
microinjection cannulae in the OVLT did not show a significant
decrease in SI time (Table 1, F(1,10) 5 0.7; p 5 0.42) or physio-
logical reactivity to lactate infusions on postpump day 4 as com-
pared with baseline (Table 3). Direct injection of lactate into the
OVLT in these rats also failed to elicit any physiological or
behavioral responses (Table 4). Because there was no significant
lactate response, these animals were not injected with TTX into
the OVLT. When GAD activity in the DMH was measured in
these animals, there were no significant differences in the pump
versus nonpump (Table 2) sides, indicating that D-AG is indeed
an inactive isomer.
Rats that were assigned to L-AG pumps in the DMH and
microinjection cannulae 1 mm lateral to the OVLT, i.e., mePOA,
showed a significant decrease in SI time on postpump day 4 as
compared with baseline (Table 1; F(1,10) 5 73.7; p 5 0.0001). On
postpump day 4 these animals also had become reactive to intra-
venous lactate infusions, with significant increases in HR and BP
(Table 3). Injection of TTX or vehicle into the mePOA, followed
by infusion of intravenous sodium lactate in these rats, revealed
that TTX not only failed to block the HR and BP responses to
lactate infusions but in fact significantly increased the HR re-
sponses (Table 3). When saline or sodium lactate was injected
directly into the mePOA of these rats on postpump day 5, they
showed no significant increases in HR, BP, and locomotor activity
(Table 4). Measuring GAD activity in the DMH revealed that
these animals also had significant decreases in GAD activity on
the pump side as compared with the nonpump side (Table 2;
F(1,10) 5 25.4; p 5 0.0005). A photomicrograph of the histological
section confirming the site of injection in the region of the
mePOA is shown in Figure 5. Thus, in this group with unilateral
GABA dysfunction in the DMH, blocking neuronal activity in
the mePOA with TTX enhanced the lactate response, whereas
direct injections of lactate into the mePOA elicited no physiolog-
ical or behavioral responses.
Finally, rats that had L-AG pumps in the DMH and microin-
jection cannulae in the SFO also showed a significant decrease in
SI time (Table 1; F(1,10) 5 41.8; p 5 0.0001) and physiological
reactivity to intravenous lactate on postpump day 4 as compared
with baseline (Table 3). Injection of TTX into the SFO, followed
by infusion of intravenous sodium lactate in these rats, failed to
block the HR and BP responses to lactate infusions (Table 3).
When sodium lactate was injected directly into the SFO of these
rats on postpump day 5, they also showed significant increases in
HR, BP, and locomotor activity (Fig. 6) but were less robust than
those elicited in the OVLT. Measuring GAD activity in the
DMH revealed that these animals also had significant decreases
in GAD activity on the pump side as compared with the nonpump
side (Table 2; F(1,10) 5 4.99; p 5 0.05). Figure 7 shows a repre-
sentative histological verification of the site of injection in the
SFO. Thus, in rats with unilateral GABA dysfunction in the
DMH, blocking neuronal activity in the SFO with TTX failed to
Figure 4. Representative photomicrograph of histological sections (mag-
nification, 83) showing the site of microinjection cannula implantation
(marked by arrow) in the OVLT. The sites were marked by injecting 100
nl of 50% India ink. ACA, Anterior commissure, anterior; HDB, horizon-
tal limb of the diagonal band; MS, medial septal nucleus; OVLT, organum
vasculosum lamina terminalis; VDB, vertical limb of the diagonal band;
2N, optic nerve.
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block the lactate response, whereas direct injections of lactate
into the SFO elicited physiological or behavioral responses.
DISCUSSION
The above and previous findings suggest that the DMH may be a
critical site in rats that is capable of generating a full panic-like
anxiety response. This anxiety circuit appears to be normal under
tonic GABAergic inhibition; removing this inhibition elicits sud-
den, dramatic increases in physiological measures of heart rate,
respiratory rate, blood pressure (DiMicco and Abshire, 1987;
DiMicco et al., 1992), plasma catecholamine (Wible et al., 1989),
corticosterone levels (Keim and Shekhar, 1996), “flight” behavior
(Shekhar and DiMicco, 1987), and selective enhancement of
“fear” responses (Shekhar et al., 1987) plus an increase in exper-
imental anxiety as measured in a variety of behavioral tests
(Shekhar et al., 1990; Shekhar, 1993; Shekhar and Katner, 1995).
This response can be blocked by imipramine and clonazepam,
two of the effective treatments for human panic disorder (Shek-
har, 1994). It should be noted that acute disruption of GABA
inhibition in the DMH does not mimic human panic attacks
precisely, because increases in plasma catecholamines and corti-
costerone are not seen consistently during human panic attacks.
However, chronic dysfunction in the DMH results in the devel-
opment of lactate sensitivity similar to patients with panic disor-
der (Shekhar et al., 1996). The present study was conducted to
clarify some of the potential pathways for the development of the
lactate-induced anxiety response in rats with DMH GABA
dysfunction.
The above results clearly show that blocking neuronal activity
in the OVLT with TTX completely blocks the lactate response in
rats with a compromised DMH, indicating that the OVLT indeed
may be the primary site that conveys the peripheral lactate stim-
ulus to the DMH (see Fig. 2). This stimulus in turn elicits a full
physiological and behavioral response only when DMH function
is compromised, as in rats infused with L-AG, a GABA synthesis
inhibitor. In rats infused with D-AG, the inactive isomer, there
was no decrease in the DMH GAD activity, and when the DMH
was thus normal, there were no physiological /behavioral re-
sponses to either intravenous lactate infusions (Table 3) or direct
lactate injections into the OVLT (Table 4). Therefore, a combi-
nation of a compromised central panicogenic site, such as the
DMH, and the excitatory input from the CVOs, such as the
OVLT, appears to be necessary for lactate-induced responses.
In the current study the only test of “anxiety” used is the SI
test. Previous studies have shown that infusion of L-AG into the
DMH of rats causes anxiety-like responses in the SI as well as in
the elevated plus-maze tests (Shekhar et al., 1996). However,
Table 3. Effects of intravenous lactate infusions in rats implanted with Alzet pumps, infusing either D- or L-allylglycine (D- or L-AG, the inactive and
active isomers, respectively) into the DMH
Pump type in the DMH
Day of intravenous
lactate infusions
Site and type of mi-
croinjection before
lactate infusions
Changes in HR after
lactate infusion
(beats/min)
Changes in BP after
lactate infusion
(mm of Hg)
D-Allylglycine Baseline (before pump) None 24 6 6 22 6 4
(n 5 6) Day 4 after pump None 23 6 4 1 6 5
L-Allylglycine Baseline None 27 6 3 3 6 3
(n 5 6) Day 4 after pump None 104 6 6* 18 6 4*
Days 6/7 after pump SFO; a-CSF 90 6 4* 17 6 2*
Days 6/7 after pump SFO; TTX 124 6 22* 28 6 4*#
L-Allylglycine Baseline None 25 6 9 4 6 3
(n 5 6) Day 4 after pump None 75 6 8* 17 6 4*
Days 6/7 after pump mePOA; a-CSF 70 6 4* 14 6 2*
Days 6/7 after pump mePOA; TTX 122 6 9*# 20 6 5*
Rats were implanted with Alzet pumps into the DMH, infusing either the inactive D-isomer of the GABA synthesis inhibitor allylglycine (D-AG) or the active isomer L-AG;
the effects of intravenous lactate infusions were tested 4 d after pump implantations. The rats implanted with D-AG pumps were not microinjected with tetrodotoxin into the
OVLT, because they were not reactive to intravenous lactate infusions. The D-AG pump rats without GABA dysfunction in the DMH did not develop physiological reactivity
to lactate infusions. The L-AG pump rats had another cannula implanted in either the subfornical organ (SFO) or the medial preoptic area (mePOA). Unlike the OVLT,
injection of tetrodotoxin into these sites did not block the response elicited by intravenous sodium lactate infusions.
Table 4. Effects of directly microinjecting different amounts of either saline or lactate solutions into the circumventricular sites in rats implanted
with Alzet pumps in the DMH
Type of pump in
the DMH
Site of micro-
injection
Solution mi-
croinjected
Changes in HR
(beats/min)
Changes in BP
(mm of Hg)
Number of
crossings/5 min
Number of
rearings/5 min
D-Allylglycine OVLT Saline 100 nl 2 6 2 21 6 3 0 6 1 0 6 1
(n 5 6) Lactate 100 nl 23 6 3 2 6 2 1 6 1 0 6 0
Saline 500 nl 6 6 2 4 6 3 0 6 0 0 6 0
Lactate 500 nl 3 6 1 3 6 2 0 6 1 1 6 1
L-Allylglycine mePOA Saline 100 nl 4 6 1 4 6 2 0 6 1 0 6 0
(n 5 6) Lactate 100 nl 4 6 4 3 6 1 0 6 1 0 6 0
Saline 500 nl 2 6 3 4 6 1 0 6 0 1 6 1
Lactate 500 nl 3 6 3 6 6 2 1 6 1 0 6 1
Rats were implanted with Alzet pumps into the DMH, infusing the GABA synthesis inhibitor L-AG or its inactive isomer D-AG. These rats also were implanted with their
appropriate CVO cannulae for direct lactate injections into the CVO sites. Neither injecting lactate into the OVLT of rats with the inactive isomer D-AG pumps in the DMH
nor injecting lactate into the mePOA of rats with the active L-AG pump in the DMH elicited a panic-like response.
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because there is considerable variance in the effects of experi-
mental interventions on the response of rats in different tests of
anxiety, the limitations of using only one test of anxiety need to
be noted.
There is also significant controversy as to the meaning of the
lactate sensitivity seen in patients with panic disorder. There is
some conflicting evidence about whether peripheral lactate infu-
sions even cross into the CNS. Although some studies have noted
that peripherally infused lactate does enter the brain in rodents
(Dager et al., 1992) and humans (Dager et al., 1994), others have
suggested that it does not (Coplan et al., 1992). As proposed in the
present study, if peripheral lactate acts via the CVOs that lack a
blood–brain barrier, then the CNS penetration of lactate becomes
immaterial. Although lactate infusions clearly cause panic attacks
in panic patients, it is possible that these patients simply have a
heightened physiological arousal and are likely to respond with a
panic attack to a variety of physiological stimuli. This is, in fact, the
case because panic patients are sensitive to many “panicogenic”
agents such as yohimbine, caffeine, cholecystokinin, CO2, etc. If
GABA dysfunction in the DMH of rats does mimic panic disorder,
then these rats also would be sensitive to some of the other
panicogenic agents in addition to lactate. In a preliminary study of
a group of rats with L-AG pumps in the DMH that were tested with
both intravenous lactate and yohimbine infusions, there were sim-
ilar physiological and anxiogenic responses to both agents, suggest-
ing that this indeed may be the case (Table 5).
The connections of the CVOs, the DMH, and its projections
involved in the lactate response are summarized in Figure 8. The
OVLT has strong connections with the DMH (Ter Horst and
Luiten, 1986). Under normal conditions the excitatory input from
the OVLT, which may involve angiotensin pathways (A. Shekhar
and S. Keim, unpublished observations), is unable to elicit the
DMH-mediated response because of the presence of a tonic
GABAergic inhibition in the DMH. When this normal inhibitory
tone in the DMH is compromised, stimulation of the OVLT by
lactate infusions in turn would activate the physiological and
behavioral responses via the DMH. The SFO, another CVO in
the anterior third ventricle close to the DMH, also may activate
a similar response but appears to use the OVLT as an interme-
diate relay center via its reciprocal connections (Johnson and
Gross, 1993), because in rats that had TTX injected into the
OVLT, an intact SFO alone was unable to elicit the response to
intravenous lactate infusions (Fig. 8). Injection of TTX into the
mePOA not only was unable to block but in fact enhanced some
of the responses (such as HR) elicited by systemic lactate infu-
sions (Table 3). The mePOA has connections with both the
OVLT and SFO as well as with the DMH (Saper and Levisohn,
1983), and the overall effect of blocking the mePOA appears to be
a net loss of inhibition on the DMH response. Once activated, the
DMH has efferent projections to a number of areas that regulate
emotional and physiological responses, including the following:
the PVN (Ter Horst and Luiten, 1986), a major site for endocrine
and autonomic outputs (Swanson, 1987); the lateral hypothala-
mus (Ter Horst and Luiten, 1986), a relay center for autonomic
responses associated with emotional reactions (LeDoux et al.,
1988); bed nucleus of stria terminalis, hippocampus, and frontal
cortex (Swanson, 1987), regions known to be associated with
emotions and learning; periaqueductal gray at the level of cranial
nerve III (Watson et al., 1982; Ter Horst and Luiten, 1986),
another site involved in physiological and behavioral effects of
emotional responses; nucleus tractus solitarius, site of sensory
information from peripheral autonomic structures; pressor area
of the ventrolateral medulla, site that regulates the sympathetic
tone; nucleus ambiguus and dorsal motor nucleus of the vagus,
major parasympathetic output areas (Ter Horst and Luiten,
1986); and the intermediolateral column of the spinal cord, site of
the preganglionic sympathetic neurons (Saper et al., 1976).
Therefore, the connections of the DMH are such that it is able to
be a coordinated output center of stress responses (Fig. 8). In-
deed, the DMH has been described as a major integrator of
emotional and autonomic responses (Bernardis and Bellinger,
1987; DiMicco et al., 1992).
The pathways between the CVOs and the hypothalamus are
essential for many homeostatic regulatory mechanisms. In fact, it
is suggested that the development of these interoceptor pathways
may have been critical in the evolution of biological species that,
by their interoceptor role, are thought to be capable of generating
powerful emotional and behavioral drives (Denton et al., 1996).
Activation of such pathways in the absence of normal regulatory
mechanisms conceivably could lead to a panic-like response, an
Figure 5. Photomicrograph of a histological section (magnification, 83)
showing the site of microinjection cannula implantation (marked by
arrow) in the mePOA. The sites were marked by injecting 100 nl of 50%
India ink. AC, Anterior commissure; F, fornix; MPA, medial preoptic
area.
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essential survival reflex. In addition to the DMH, there are other
CNS regions capable of eliciting physiological and behavioral
responses when the local GABAergic inhibition is removed, such
as the basolateral amygdala (Sanders and Shekhar, 1991, 1995)
and the midbrain central gray (DiScala et al., 1984). These struc-
tures also have close connections with the CVOs (Johnson and
Gross, 1993) and may be capable of becoming neural substrates
for abnormal panic-like responses when their function is compro-
mised. For example, the basolateral amygdala appears to develop
a form of long-term sensitization after repeated GABA blockade,
leading to chronic high levels of anxiety in rats (Sanders et al.,
1995). Preliminary studies indicate that these sensitized rats also
may become responsive to lactate infusions (T. Sajdyk and A.
Shekhar, unpublished observations). The SFO has extensive con-
nections with the amygdala (Johnson and Gross, 1993) and may
be an important site in eliciting the lactate response in the
amygdala-primed rats (A. Shekhar and S. Keim, unpublished
observations). Thus a variety of forebrain and brainstem struc-
tures that are substrates for the anxiety responses may become
the pathological sites in the development of panic disorders.
The involvement of the CVOs in the lactate-induced panic
response also may explain why patients with panic disorder are
susceptible to induction of panic response by systemic adminis-
trations of a variety of agents like CO2 , caffeine, cholecystokinin,
norepinephrine, and others (Price et al., 1995). Many of these
agents, like lactate, cholecystokinin, and norepinephrine, do not
cross the blood–brain barrier easily. However, the CVOs, which
lack a blood–brain barrier, can be exposed easily to these circu-
lating substances and in turn stimulate the compromised panic-
generating site (such as the DMH or amygdala), thereby eliciting
a response. Such a mechanism also could present a single unifying
explanation for the existence of multiple, apparently unrelated
agents that seem to induce a panic attack in patients suffering
from panic disorder.
In summary, this report presents evidence supporting a specific
circuit involving a compromised DMH and the anterior third
ventricular circumventricular organs, OVLT and SFO, which are
capable of eliciting an anxiety response after intravenous lactate
infusions. We believe this to be the first description of a putative
neuroanatomical pathway for the lactate sensitivity in patients
with panic disorder, a phenomenon that has been known for three
decades (Pitts and McClure, 1967). In addition, this may provide
a starting point for a more detailed delineation of the neural
circuitry involved in such responses and the development of panic
disorders.
Figure 6. Changes (mean 6 SEM) in (A) heart rate (HR), (B) blood pressure (BP), (C) number of cage crossings, and (D) rearings after direct
injections of either sodium lactate (100 and 500 nl of 0.5N solution) or saline (100 or 500 nl) into the SFO of rats that had L-AG Alzet infusion pumps
implanted into the DMH for 5 d. Direct injection of lactate into the SFO in these rats also elicited a panic-like response that was less robust than the
response elicited by injecting lactate into the OVLT. Symbols show significant difference from saline control (*) and 100 nl of lactate (#) by repeated
measures ANOVA with Fisher’s LSD; p , 0.05.
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Figure 8. Simplified schematic representation of the connec-
tions of the circumventricular organs and the DMH that may
be involved in the lactate response. Many other connections
of the DMH are not included for the sake of simplicity. It is
suggested that the OVLT acts as the primary sensory site for
peripheral lactate input and in turn activates the DMH to
elicit a panic response. AII, Angiotensin II; BP, blood pres-
sure; CG, central gray; DMH, dorsomedial hypothalamus;
EAA, excitatory amino acids; GABA, g-aminobutyric acid;
HR, heart rate; IML, intermediolateral column of the spinal
cord; LC, locus ceruleus; LH, lateral hypothalamus; mePOA,
medial preoptic area; NTS, nucleus of tractus solitarius;
OVLT, organum vasculosum lamina terminalis; PVN, para-
ventricular nucleus of the hypothalamus; RR, respiratory
rate; SFO, subfornical organ.
Table 5. Effects of different intravenous infusions in rats implanted
with Alzet pumps, infusing L-allylglycine (L-AG, the GABA synthesis
inhibitor) into the DMH
Intravenous
infusion type
HR
(beats/min)
BP
(mm of Hg)
SI
(seconds)
Saline 1 6 5 6 6 4 38 6 3
Sodium lactate 110 6 10* 43 6 11* 13 6 2*
Yohimbine 112 6 19* 50 6 4* 11 6 1*
Rats (n 5 3) were implanted with Alzet pumps into the DMH, infusing the GABA
synthesis inhibitor L-AG. On postpump days 4, 6, and 8 they were given intravenous
infusions of either saline (10 ml/kg), sodium lactate (10 ml/kg of 0.5N solution) or
yohimbine (0.4 mg/10 ml/kg), and the effects on heart rate (HR), blood pressure
(BP), and social interaction (SI) time were measured.
*Significantly different from saline by repeated measure ANOVA, coupled with
Fisher’s LSD test; p , 0.05. Data are presented as mean 6 SEM.
4
Figure 7. Photomicrograph of a histological section (magnification, 83)
showing the site of microinjection cannula implantation (marked by
arrow) in the SFO. The sites were marked by injecting 100 nl of 50% India
ink. cc, Corpus callosum; PT, paratenial thalamic nucleus; PVA, paraven-
tricular thalamic nucleus, anterior; SFO, subfornical organ; Sm, stria
medullaris thalami; VHC, ventral hippocampal commissure.
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